Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 20.70
-0.80 (-3.72%)
At close: Apr 22, 2026
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 119.39 million as of April 22, 2026. Its market cap has decreased by -10.76% in one year.
Market Cap
119.39M
Enterprise Value
266.90M
Revenue
839.38K
Ranking
n/a
PE Ratio
4.56
Stock Price
20.70
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 119.39M, a decrease of -50.35%. That is a compound annual growth rate of -15.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 124.00M | -12.96% |
| Dec 30, 2025 | 142.46M | -2.32% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 930.57M |
| Basilea Pharmaceutica AG | 678.50M |
| Newron Pharmaceuticals | 341.22M |
| Santhera Pharmaceuticals Holding AG | 238.14M |
| BioVersys AG | 174.86M |
| Molecular Partners AG | 128.32M |
| EvoNext Holdings | 6.56M |
| Addex Therapeutics | 5.48M |